Image For Activity Cover
ORN Spring 2022 #2 - Case Studies and QandA: The impact of illicit fentanyl use on opioid use disorder treatment
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.

This course was originally offered as part of "ORN - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series (On-Demand)" course. If you took or registered for that course, you will not be able to access this course.
Learning Objectives
At the conclusion of this webinar, attendees will be able to:
  • Understand the scope of buprenorphine-precipitated withdrawal
  • Learn strategies for buprenorphine inductions from case studies
  • Discuss approaches to improve OUD treatment for persons who use fentanyl
Claim Credit & Course Material

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Credit Statement
This webinar has been approved for a maximum 1, AOA Category 1-A CME credits, and AOA designates this for a maximum of 1, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.
Speaker

Andrew Huhn, PhD., M.B.A.

My research is focused on understanding the human experience of opioid use and opioid use disorder (OUD). The majority of my work has been in human laboratory studies and clinical trials, and I have leveraged my background in psychology, neuroscience, and behavioral pharmacology to identify risk factors for illicit drug relapse and medication strategies to improve OUD treatment outcomes. These studies cover the continuum of care, including supervised opioid withdrawal and sustained recovery using medications for OUD. Topics of interest include sleep disturbance, drug craving, and diurnal measures of stress and mood. In addition, my work in OUD patients has naturally led me to investigate the tradeoffs between the abuse liability and analgesic efficacy of opioid medications, including research on persons with chronic and/or acute pain. My lab employs diverse methodological approaches to better understand opioid use and OUD, including neuroimaging, ecological momentary assessments, wearable technologies, human laboratory studies, and survey research. Taken together, this research is aimed at improving treatment outcomes directly and evaluating and strategizing macro-level changes to improve healthcare for substance use and related disorders.

Summary
Availability: On-Demand
Expires on Apr 30, 2025
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Recommended
Powered By